MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
Xiaoyue XuShaorong YuWenbo SunXiaobing QinYan ChenLeilei ZhouRui LouShuchen DongBo ShenJianzhong WuJialan ZangHaixia CaoMeiqi ShiQin ZhangJi-Feng FengPublished in: Journal of cancer research and clinical oncology (2017)
Our miRNA CI formula can act as an independent predictor to predict the response of patients with lung adenocarcinoma to platinum-based chemotherapy.
Keyphrases